Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation

Published:2001-08 Issue:8 Volume:7 Page:439-445
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Bubalo Joseph,Seelig Florence,Karbowicz Sean,Maziarz Richard T.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference18 articles.

1. Anzemet injection, dolasetron mesylate injection prescribing information [package insert],1999

2. Zotran, ondansetron hydrochloride prescribing information [package insert],1999

3. Kytril, granisetron hydrochloride injection prescribing information [package insert],1998

4. Kytril, granisetron hydrochloride tablets prescribing information [package insert],1999

5. Anzemet tablets, dolastron mesylate prescribing information [package insert],1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation;Journal of Oncology Pharmacy Practice;2023-05-07

2. A Phase II Trial of Netupitant/Palonosetron for Prevention of Chemotherapy Induced Nausea/Vomiting in Patients Receiving BEAM Prior to Hematopoietic Cell Transplantation;2022-11-03

3. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-11-16

4. A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT);Bone Marrow Transplantation;2018-02-20

5. Update and new trends in antiemetic therapy: the continuing need for novel therapies;Annals of Oncology;2011-01